Min Son of Hanol IP & Law reports on a revision of the Korean Design Protection Act that will relax several restrictions and improve procedural practices
Min Son of Hanol IP & Law explains how the timing of a claim for novelty affects the procurement or enforceability of design rights after a ruling on a case with a surprising twist
Min Son of Hanol IP & Law finds encouragement for developers of new chemical entity drugs after the rulings handed down in a battle between AstraZeneca and several generic pharmaceutical companies
